C5AR1 and COVID-19: Although complement activation can occur via convertase-dependent or convertase-independent pathways (e.g., thrombin cleaving C5 to C5a) in inflammatory settings such as lung injury and/or sepsis (35), multiple direct interactions between coronaviruses and the complement system may partly explain the elevated levels of these markers in patients with COVID-19 compared to the other etiologies.